Methods for providing localized therapeutic heat to biological tissues and fluids

• US 5,149,319 A
• Filed: 09/11/1990
• Issued: 09/22/1992
• Est. Priority Date: 09/11/1990
• Status: Expired due to Term

• Current Assignee: Cerevast Therapeutics, Inc.
• Original Assignee: Evan C. Unger
• Inventors: Unger, Evan C.
• Primary Examiner(s): Rosenbaum, C. Fred
• Assistant Examiner(s): SMITH, CHALIN A
• Application Number:
  US07/581,027
• Time in Patent Office: 742 Days
• Field of Search: 604/22, 604/20, 128/660.01, 128/660.02, 128/660.03, 128/660.07, 128/662.02, 128/653, 128/804, 128/24 EL, 128/24 R, 128/24 AA, 424/2, 424/7.1, 424/9, 73/194 A, 600/10, 600/12
• US Class Current: 604/22
• CPC Class Codes: A61B 2017/00716 simulating physical properties
• CPC Class Codes: A61B 2017/22088 ultrasound absorbing, drug activated by ultrasound
• CPC Class Codes: A61K 41/0052 Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
• CPC Class Codes: A61K 9/127 Liposomes
• CPC Class Codes: A61M 2202/0476 Oxygenated solutions
• CPC Class Codes: A61N 2007/025 interstitial
• CPC Class Codes: A61N 7/02 Localised ultrasound hyperthermia hyperthermia in general A61F7/00
• CPC Class Codes: A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Gas, gaseous precursors and prefluorocarbons are presented as novel potentiators for ultrasonic hyperthermia. The gas, gaseous precursors and perfluorocarbons which may be administered into the vasculature, interstitially or into any body cavity are designed to accumulate in cancerous and diseased tissues. When therapeutic ultrasonic energy is applied to the diseased region heating is increased because of the greater effectiveness of sound energy absorption caused by these agents.

Claims

1. A method for heat treating biological tissues and fluids which comprises:

(i) administering to the tissue or fluid to be treated a therapeutically effective amount of a hyperthermia potentiator selected from the group consisting of gas, gaseous precursors and perfluorocarbons; and

(ii) applying ultrasound to heat said tissue or fluid to a temperature of at least about 43°

C.

2. A method of claim 1 wherein said hyperthermia potentiator is selected from the group consisting of gas, gaseous precursors and perfluorocarbons.

3. A method of claim 2 wherein said hyperthermia potentiator is gas.

4. A method of claim 3 wherein said gas is selected from the group consisting of air, carbon dioxide, oxygen, nitrogen, xenon, argon, neon and helium.

5. A method of claim 3 wherein said gas consists of stabilized gas bubbles.

6. A method of claim 5 wherein said stabilized gas bubbles consist of stabilized air bubbles.

7. A method of claim 2 wherein said hyperthermia potentiator is a gaseous precursor.

8. A method of claim 7 wherein said gaseous precursor is selected from the group consisting of aminomalonate, sodium bicarbonate, methylactate and diazonium compounds.

9. A method of claim 2 wherein said hyperthermia potentiator is a perfluorocarbon.

10. A method of claim 9 wherein said perfluorocarbon is selected from the group consisting of perfluorooctyl iodide, perfluorotributylamine, trifluoropropylamine or perfluorooctlybromide.

11. A method of claim 1 wherein said hyperthermia potentiator is encapsulated in a liposome.

12. A method of claim 3 wherein said hyperthermia potentiator is encapsulated in a liposome.

13. A method of claim 7 wherein said hyperthermia potentiator is encapsulated in a liposome.

14. A method of claim 9 wherein said hyperthermia potentiator is encapsulated in a liposome.